Federal lawyers last week agreed with national groups that represent 340B hospitals that the U.S. Supreme Court’s June decision to declare illegal Medicare Part B payment cuts in 2018 and 2019 for hospitals’ 340B-purchased drugs “effectively resolves” the groups’ claims relating to payment cuts in 2020, 2021, and 2022.
Lawyers for the U.S. Health and Human Services Department (HHS) said in a Sept. 14 brief filed in U.S. District Court for the District of Columbia that HHS does not oppose the hospital groups’ motion for “a declaration that the 2020, 2021, and 2022 [hospital outpatient prospective payment system, or OPPS] rules are unlawful insofar as they vary the reimbursement rate for 340B hospitals from ASP plus six percent absent a survey of hospitals’ acquisition costs.”
Federal lawyers last week agreed with national groups that represent 340B hospitals that the U.S. Supreme Court’s June decision to declare illegal Medicare Part B payment cuts in 2018 and 2019 for hospitals’ 340B-purchased drugs “effectively resolves” the groups’ claims relating to payment cuts in 2020, 2021, and 2022.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
